LivaNova PLC Share Price London S.E.
Equities
LIVN
GB00BYMT0J19
Medical Equipment, Supplies & Distribution
Sales 2024 * | 1.22B 95.73B | Sales 2025 * | 1.28B 101B | Capitalization | 3.31B 260B |
---|---|---|---|---|---|
Net income 2024 * | 39M 3.07B | Net income 2025 * | 91M 7.17B | EV / Sales 2024 * | 2.64 x |
Net cash position 2024 * | 102M 8.05B | Net cash position 2025 * | 231M 18.16B | EV / Sales 2025 * | 2.41 x |
P/E ratio 2024 * |
88.8
x | P/E ratio 2025 * |
35.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.87% |
Latest transcript on LivaNova PLC
Managers | Title | Age | Since |
---|---|---|---|
Alex Shvartsburg
DFI | Director of Finance/CFO | 54 | 31/12/16 |
William Kozy
CHM | Chairman | 72 | 11/06/18 |
Matt J. Dodds
CTO | Chief Tech/Sci/R&D Officer | - | 07/01/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 02/12/20 | |
Peter Wilver
BRD | Director/Board Member | 64 | 12/06/22 |
William Kozy
CHM | Chairman | 72 | 11/06/18 |
1st Jan change | Capi. | |
---|---|---|
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+9.25% | 42.5B | |
+15.97% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |